V
Voyager Therapeutics
Cambridge, United States
Founded 2014 NASDAQ: VYGR
Nanomedicine Gene Therapy Delivery Nano-Bio Protein Nanoparticles Regenerative Medicine Drug Delivery
About
AAV capsid engineering for CNS gene therapy delivery
Company Details
- Type
- public
- Employees
- 150+
- Funding
- Public
Key Products
- TRACER Capsids
- Gene Therapy